CoChat

Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator

Open access
Chatterjee, Snehajyoti, Cassel, Raphaelle, Schneider‐Anthony, Anne, Merienne, Karine, Cosquer, Brigitte, Tzeplaeff, Laura, Halder Sinha, Sarmistha, Kumar, Manoj, Chaturbedy, Piyush, Eswaramoorthy, Muthusamy, Le Gras, Stéphanie, Keime, Céline, Bousiges, Olivier, Dutar, Patrick, Petsophonsakul, Petnoi, Rampon, Claire, Cassel, Jean‐Christophe, Buée, Luc, Blum, David, Kundu, Tapas K, Boutillier, Anne‐Laurence · 2018 · EMBO Molecular Medicine
Cited by 99

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Chromatin acetylation, a critical regulator of synaptic plasticity and memory processes, is thought to be altered in neurodegenerative diseases. Here, we demonstrate that spatial memory and plasticity (LTD, dendritic spine formation) deficits can be restored in a mouse model of tauopathy following treatment with CSP‐TTK21, a small‐molecule activator of CBP/p300 histone acetyltransferases (HAT). At the transcriptional level, CSP‐TTK21 re‐established half of the hippocampal transcriptome in learning mice, likely through increased expression of neuronal activity genes and memory enhancers. At the epigenomic level, the hippocampus of tauopathic mice showed a significant decrease in H2B but not H3K27 acetylation levels, both marks co‐localizing at TSS and CBP enhancers. Importantly, CSP‐TTK21 treatment increased H2B acetylation levels at decreased peaks, CBP enhancers, and TSS, including genes associated with plasticity and neuronal functions, overall providing a 95% rescue of the H2B acetylome in tauopathic mice. This study is the first to provide in vivo proof‐of‐concept evidence that CBP/p300 HAT activation efficiently reverses epigenetic, transcriptional, synaptic plasticity, and behavioral deficits associated with Alzheimer's disease lesions in mice. Epigenetic dysfunctions related to H2B histone acetylation were shown in the hippocampus of a mouse model of Alzheimer's disease. A therapeutic strategy aimed at activating CBP/p300 acetyltransferase revealed efficient at rescuing neuronal activity, plasticity and memory in these mice. Epigenetic dysfunctions related to H2B histone acetylation were shown in the hippocampus of a mouse model of Alzheimer's disease. A therapeutic strategy aimed at activating CBP/p300 acetyltransferase revealed efficient at rescuing neuronal activity, plasticity and memory in these mice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/emmm.201708587

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 99

Metadata

Authors
Chatterjee, S., Cassel, R., Schneider‐Anthony, A., Merienne, K., Cosquer, B., Tzeplaeff, L., Halder Sinha, S., Kumar, M., Chaturbedy, P., Eswaramoorthy, M., Le Gras, S., Keime, C., Bousiges, O., Dutar, P., Petsophonsakul, P., Rampon, C., Cassel, J., Buée, L., Blum, D., Kundu, T. K., & Boutillier, A.
Venue
EMBO Molecular Medicine
Published
2018-10
Volume
10
Issue
11
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W2894821853
Cited by
99
References
24
FWCI
7.27
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator. https://app.cochat.ai/papers/10.15252/emmm.201708587
The paper
Chatterjee, S., Cassel, R., Schneider‐Anthony, A., Merienne, K., Cosquer, B., Tzeplaeff, L., Halder Sinha, S., Kumar, M., Chaturbedy, P., Eswaramoorthy, M., Le Gras, S., Keime, C., Bousiges, O., Dutar, P., Petsophonsakul, P., Rampon, C., Cassel, J., Buée, L., Blum, D., . . . Boutillier, A. (2018). Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.201708587

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.